Trevena, Inc. (TRVN) News Headlines

▮ More

Date

Headline

8/24/2020 7:38:52 AM Trevena Initiates TRV027 Study In COVID-19 Patients - Quick Facts

8/24/2020 7:14:18 AM Trevena Initiates Proof-of-concept Study For TRV027 In COVID-19 Patients

8/20/2020 6:13:22 AM Pre-market Movers In Healthcare Sector: KZIA, TRVN, SNSS, OCGN, GLPG...

8/12/2020 6:42:15 AM Pre-market Movers In Healthcare Sector: AZRX, ABUS, MRNA, MNK, TRVN…

8/11/2020 6:25:26 AM Pre-market Movers In Healthcare Sector: EQ, PFNX, SRNE, SNSS, FENC...

8/11/2020 1:57:59 AM CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs

8/10/2020 8:08:29 AM FDA Approves Trevena's Olinvyk Opioid For Use In Hospitals

8/10/2020 7:31:04 AM Pre-market Movers In Healthcare Sector: TRVN, ETON, FENC, OPGN…

8/4/2020 3:31:42 AM ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec.

8/3/2020 6:37:12 AM Pre-market Movers In Healthcare Sector: IMUX, TRVN, VAR, VTGN…

7/29/2020 12:58:26 AM Trevena (TRVN) Just Days Away From FDA Decision

7/27/2020 4:39:15 AM Biotech Stocks Facing FDA Decision In August 2020

6/2/2020 7:13:11 AM Trevena Announces Collaboration With Imperial College London To Evaluate TRV027 In COVID-19 Patients

3/12/2020 7:14:29 AM Trevena Q4 Net Loss Attributable $6.4 Mln Or $0.07 Per Share

3/5/2020 7:19:00 AM Trevena Reports FDA Set PDUFA Date Of August 7, 2020 For Oliceridine

2/10/2020 7:04:39 AM Trevena Resubmits NDA To FDA For IV Oliceridine

12/23/2019 7:09:47 AM Trevena Begins Proof-of-Concept Study For TRV734 For Potential Treatment Of Opioid Use Disorder

6/27/2019 7:14:09 AM Trevena Appoints Barry Shin As CFO

3/13/2019 7:18:54 AM Trevena Q4 Net Loss Attributable $8.0 Mln Or $0.10 Per Share

1/30/2019 7:48:18 AM What's Making News At Roche, EYEN, STML, Sirona, TRVN?